Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). Issue 2 (30th May 2018)
- Record Type:
- Journal Article
- Title:
- Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). Issue 2 (30th May 2018)
- Main Title:
- Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)
- Authors:
- Brown, Justin C
Zhang, Sui
Niedzwiecki, Donna
Saltz, Leonard B
Mayer, Robert J
Mowat, Rex B
Whittom, Renaud
Hantel, Alexander
Benson, Al
Atienza, Daniel
Messino, Michael
Kindler, Hedy
Venook, Alan
Ogino, Shuji
Li, Yanping
Zhang, Xuehong
Ng, Kimmie
Willett, Walter C
Giovannucci, Edward L
Fuchs, Charles S
Meyerhardt, Jeffrey A - Abstract:
- Abstract: Background: Energy balance–related risk factors for colon cancer recurrence and mortality—type II diabetes, hyperinsulinemia, inflammation, and visceral obesity—are positively correlated with consumption of refined grains and negatively correlated with consumption of whole grains. We examined the relationship between the consumption of refined and whole grains with cancer recurrence and mortality in a cohort of patients with colon cancer. Methods: We conducted a prospective observational study of 1024 patients with stage III colon cancer who participated in a randomized trial of postoperative chemotherapy. Patients reported consumption of refined and whole grains using a food frequency questionnaire during and six months after chemotherapy. The primary outcome was disease-free survival (DFS). Multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox regression models. All P values are two-sided. Results: During a median follow-up of 7.3 years, 394 patients experienced a DFS event. The hazard ratio for DFS was 1.56 (95% CI = 1.09 to 2.24) for patients consuming three or more servings per day of refined grains compared with patients consuming less than one serving per day ( P trend = .005). The hazard ratio for DFS was 0.89 (95% CI = 0.66 to 1.20) for patients consuming three or more servings per day of whole grains compared with patients consuming less than one serving per day ( P trend = .54). The hazard ratio for DFS ofAbstract: Background: Energy balance–related risk factors for colon cancer recurrence and mortality—type II diabetes, hyperinsulinemia, inflammation, and visceral obesity—are positively correlated with consumption of refined grains and negatively correlated with consumption of whole grains. We examined the relationship between the consumption of refined and whole grains with cancer recurrence and mortality in a cohort of patients with colon cancer. Methods: We conducted a prospective observational study of 1024 patients with stage III colon cancer who participated in a randomized trial of postoperative chemotherapy. Patients reported consumption of refined and whole grains using a food frequency questionnaire during and six months after chemotherapy. The primary outcome was disease-free survival (DFS). Multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox regression models. All P values are two-sided. Results: During a median follow-up of 7.3 years, 394 patients experienced a DFS event. The hazard ratio for DFS was 1.56 (95% CI = 1.09 to 2.24) for patients consuming three or more servings per day of refined grains compared with patients consuming less than one serving per day ( P trend = .005). The hazard ratio for DFS was 0.89 (95% CI = 0.66 to 1.20) for patients consuming three or more servings per day of whole grains compared with patients consuming less than one serving per day ( P trend = .54). The hazard ratio for DFS of substituting one serving per day of refined grain with one serving per day of whole grain was 0.87 (95% CI = 0.79 to 0.96, P = .007). Conclusions: The choice of grain consumed may be associated with cancer recurrence and mortality. Future studies are necessary to confirm our findings and to inform the design of randomized trials. … (more)
- Is Part Of:
- JNCI cancer spectrum. Volume 2:Issue 2(2018)
- Journal:
- JNCI cancer spectrum
- Issue:
- Volume 2:Issue 2(2018)
- Issue Display:
- Volume 2, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 2
- Issue:
- 2
- Issue Sort Value:
- 2018-0002-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2018-05-30
- Journal URLs:
- http://www.oxfordjournals.org/ ↗
https://academic.oup.com/jncics ↗ - DOI:
- 10.1093/jncics/pky017 ↗
- Languages:
- English
- ISSNs:
- 2515-5091
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12361.xml